Investing Profile

Dan Janney

InvestorVC
Managing Director at Alta Partners
altapartners.com/leadership/d...San Francisco, California
Photo of Dan Janney, Managing Partner at Alta Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Alta Partners Managing Partner
$100K - $5.0M
$1.5M
16
$130M
CompanyStageDateRound SizeTotal Raised
Progentos Therapeutics
Series AMay 2024$65M
$65M
Co-investors: Dmitrij Hristodorov (Forbion), Aleks Radovic-Moreno (Longwood Fund)
Edgewood Oncology
Series AMar 2024$20M
$20M
Lassen Therapeutics
Series BDec 2023$85M
$85M
Co-investors: James N. Topper (Frazier Healthcare Partners)
Novome Biotechnologies
Series BSep 2022$44M
Series AJan 2020$33M
$82M
Co-investors: Kiersten Stead (DCVC (Data Collective)), Andrew Schwab (5am Ventures)
DEM BioPharma
Series AJun 2022$70M
$70M
Co-investors: Dylan Morris (Insight Partners), Hiromichi Kimura (Astellas Venture Management), Christoph Westphal (Longwood Fund)
ImmuneID
Series AJun 2021$50M
$67M
Co-investors: Christoph Westphal (Longwood Fund), Steve Kafka (Section 32)
Virobay
Series BJul 2014$8M
Series UnknownJun 2010$10M
Debt FinancingJan 2010$300K
$18M
Evofem Biosciences
Series CFeb 2014$8M
Series CDec 2012$21M
Series CDec 2012$21M
$75M
Co-investors: Kim P. Kamdar (Domain Associates), Jenny Yip (Adjuvant Capital)